This report provides in-depth region wise and country wise analysis of the equine healthcare market. Stakeholders of this report include manufacturers of veterinary products, industry practitioners, research professionals, and new players planning to enter the market.
Presence of large numbers of players engaged in manufacturing of equine healthcare products renders
the global market increasingly fragmented. The players span across geographies, and are targeting
geographic expansion as a part of the key strategies in the equine healthcare market. A number of regional
markets have gathered momentum over the past few years. Asia Pacific has been offering new streams
of revenues to key players in the equine healthcare market.
Well-entrenched players in the global equine healthcare market are Equine Products (UK) Ltd., Ceva Santé
Animale, Vetoquinol S.A., Sanofi, and Eli Lilly and Company.
The equine industry has made considerable advances, riding on the back of large numbers of equine
events across the globe. This has propelled the need for high quality breed horses. Revival of horse racing
competitions especially in China has opened new revenue streams for manufacturers of equine healthcare
Request Brochure of Report -
Clocking a CAGR of 4.2%, the global equine healthcare market is projected to reach worth of US$862.7
mn by 2025-end.
North America and Europe Considerable See Expenditure on Equine Health
Among the various regions, North America and Europe jointly account for the majority of shares in the
global equine healthcare market. Massive increase in equine adoption rates in North America, coupled
with growing awareness about disease preventing strategies, acts as robust driver for the growth of this
regional market. Moreover, horse riding as a trend has gathered considerable momentum among young
adults, paving way for new opportunities in the regional market. Moreover, the trend of equine racing
and shows has gathered marked traction in the market. Considerable expenditure on equine health in the
regions will likely play critical role in the market’s expansion. Progress in the equine healthcare market
has also been made in post-infection illnesses.
In recent ye